WHO ICTRP trial
influence of Alogliptin on the degree of daytime sleepiness in patients with…
ChiCTR-OOC-16008298 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-OOC-16008298 |
|---|---|
| Public title | influence of Alogliptin on the degree of daytime sleepiness in patients with type 2 diabetes mellitus |
| Scientific title | influence of Alogliptin on the degree of daytime sleepiness in patients with type 2 diabetes mellitus |
| Primary sponsor | Peking University First Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Other |
| Countries | China |
| Conditions | daytime sleepness |
| Interventions | self-placebo group:placebo with metformin;self-experimental group:Alogliptin with metformin |
| Registration date | Apr 18, 2016 |
| Target size | self-placebo group:10;self-experimental group:10 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: